Delivery Order SPE2DR25D2101-SPE2DR26F46PD
- Not listed
- The Defense Logistics Agency awarded a $14,720.65 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of five (5s). This is a firm fixed price delivery order with a completion date of December 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency awarded a $24,166.47 delivery order to AmerisourceBergen Drug Corp for Aprepitant 80 mg capsule unit dose packages (6 count) on December 16, 2025, with completion scheduled for December 17, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 4,570,253,376 units of Aprepitant 40 mg capsule in unit dose packages of five on December 11, 2025, with a ceiling value of $3,267.56 and firm fixed pricing. The order is scheduled for ultimate completion on December 12, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without a set-aside designation. This award...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.13 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging. This firm fixed price, non-set-aside contract was executed on December 3, 2025, with an ultimate completion date of December 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea and vomiting (CINV) prevention medication commonly utilized in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5-count) on July 24, 2025, with a contract ceiling value of $1,698.52 and ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was performed at the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of 5s, with a ceiling value of $3,674.66 and an ultimate completion date of October 21, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Aprepitant 80 mg capsule unit dose packages in quantities of six, with a contract ceiling value of $10,700.65. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the order is scheduled for completion...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,247.16 to AmerisourceBergen Drug Corp for Aprepitant 125 mg capsule unit dose packages (quantity 6). This non-set-aside, firm fixed price delivery order was awarded on October 20, 2025, with an ultimate completion date of October 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsules with a ceiling value of $1,842.89. This competitively awarded, firm fixed-price delivery order was issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The pharmaceutical product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46PDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsules (unit dose, 5-count packaging) valued at $2,505.27 on December 17, 2025, with completion scheduled for December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a prime vendor agreement valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Aprepitant is an antiemetic medication commonly used in military and veteran healthcare settings to manage chemotherapy-induced nausea and vomiting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/16/25 |